BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35990454)

  • 1. Autocitrullination and Changes in the Activity of Peptidylarginine Deiminase 3 Induced by High Ca
    Sawata M; Shima H; Murayama K; Matsui T; Igarashi K; Funabashi K; Ite K; Kizawa K; Takahara H; Unno M
    ACS Omega; 2022 Aug; 7(32):28378-28387. PubMed ID: 35990454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocitrullination of PAD4 does not alter its enzymatic activity: In vitro and in silico studies.
    Liu X; Wichapong K; Lamers S; Reutelingsperger CPM; Nicolaes GAF
    Int J Biochem Cell Biol; 2021 May; 134():105938. PubMed ID: 33529715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
    Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
    Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation.
    Andrade F; Darrah E; Gucek M; Cole RN; Rosen A; Zhu X
    Arthritis Rheum; 2010 Jun; 62(6):1630-40. PubMed ID: 20201080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
    Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
    J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.
    Saijo S; Nagai A; Kinjo S; Mashimo R; Akimoto M; Kizawa K; Yabe-Wada T; Shimizu N; Takahara H; Unno M
    J Mol Biol; 2016 Jul; 428(15):3058-73. PubMed ID: 27393304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
    U KP; Subramanian V; Nicholas AP; Thompson PR; Ferretti P
    Biochim Biophys Acta; 2014 Jun; 1843(6):1162-71. PubMed ID: 24607566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of peptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells.
    Masutomi H; Kawashima S; Kondo Y; Uchida Y; Jang B; Choi EK; Kim YS; Shimokado K; Ishigami A
    J Neurosci Res; 2017 Jul; 95(7):1503-1512. PubMed ID: 27704563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
    Darrah E; Rosen A; Giles JT; Andrade F
    Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three isozymes of peptidylarginine deiminase in the chicken: molecular cloning, characterization, and tissue distribution.
    Shimizu A; Handa K; Honda T; Abe N; Kojima T; Takahara H
    Comp Biochem Physiol B Biochem Mol Biol; 2014 Jan; 167():65-73. PubMed ID: 24161753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland.
    Li G; Hayward IN; Jenkins BR; Rothfuss HM; Young CH; Nevalainen MT; Muth A; Thompson PR; Navratil AM; Cherrington BD
    PLoS One; 2016; 11(1):e0147503. PubMed ID: 26799659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis.
    de França NR; Ménard HA; Lora M; Zhou Z; Rauch J; Hitchon C; Andrade LEC; Colmegna I
    Arthritis Res Ther; 2022 Jan; 24(1):23. PubMed ID: 35027076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
    Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.
    Rechiche O; Lee TV; Lott JS
    Acta Crystallogr F Struct Biol Commun; 2021 Oct; 77(Pt 10):334-340. PubMed ID: 34605437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.
    Unno M; Kizawa K; Ishihara M; Takahara H
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jun; 68(Pt 6):668-70. PubMed ID: 22684066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.